随机试验报告不足:对证据综合的无声威胁
Himel Mondal1, Seshadri Reddy Varikasuvu2, Pradosh Kumar Sarangi3
1Physiology, All India Institute of Medical Sciences, Deoghar, Jharkhand, IND.
Cureus
|August 11, 2025
概括
在随机对照试验 (RCT) 中报告不足会损害基于证据的医学. 提高试验透明度和数据共享对于可靠的系统审查和临床指南至关重要.
科学领域:
- 临床研究方法论 临床研究方法论
- 证据综合 证据综合
- 医学统计 医学统计
背景情况:
- 系统性审查和元分析是基于证据的医学的基础.
- 这些审查的质量取决于报告的随机对照试验 (RCT) 的完整性和准确性.
- 尽管有像CONSORT这样的指导方针,但在RCT中仍然存在重大报告缺陷.
研究的目的:
- 突出随机对照试验 (RCT) 报告不足的关键问题.
- 强调报告不良对数据提取,综合和系统审查可靠性的负面影响.
- 倡导加强对报告标准的遵守和改进数据共享实践.
主要方法:
- 分析RCT常见报告缺陷,包括随机化,样本大小和结果数据.
- 评估不完整报告对研究透明度和可重复性的后果.
- 审查目前的指导方针和改善RCT报告的建议解决方案.
主要成果:
- 发现的关键报告缺陷包括缺乏关于RCT类型,随机化方法,组样本大小,学信息和初级结果数据的细节.
- 报告不足阻碍了数据提取和合成,损害了系统性审查和衍生的临床指南的有效性.
- 临床研究的透明度,可重复性和整体效用受到这些报告失败的威胁.
结论:
- 期刊,评论员和资助者严格执行报告标准是必不可少的.
- 鼓励研究人员在公共存储库中分享核心试验数据至关重要.
- 为了解决科学进步的这一关键障碍,对研究人员的教育举措和更强有力的问责措施是必要的.
相关概念视频
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
174
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
174
Bias in Epidemiological Studies
676
Biases can arise at various stages of research, from study design and data collection to analysis and interpretation. Recognizing and addressing these biases is essential to ensure the validity and reliability of epidemiological findings.Broadly speaking, biases in epidemiology fall into three main categories: selection bias, information bias, and confounding. A more detailed description of possible biases is:
676
Clinical Trials
8.3K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
8.3K
Blinding
2.6K
Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
2.6K
Pharmacovigilance
993
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
993
Bias
4.9K
Bias refers to any tendency that prevents a question from being considered unprejudiced. In research, bias occurs when one outcome or answer is selected or encouraged over others in sampling or testing. Bias can occur during any research phase, including study design, data collection, analysis, and publication.
In statistics, a sampling bias is created when a sample is collected from a population, and some members of the population are not as likely to be chosen as others (remember, each member...
In statistics, a sampling bias is created when a sample is collected from a population, and some members of the population are not as likely to be chosen as others (remember, each member...
4.9K


